- Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
- Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
- Chembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assay
- Chembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channel
- Chembio Diagnostics Announces Election of Leslie Teso-Lichtman to Its Board of Directors